You are here

  • Home
  • Archive
  • Volume 17, Issue 3
  • The Antiemetic Efficacy and Safety of Prophylactic Metoclopramide for Elective Cesarean Delivery during Spinal Anesthesia

Article Text

Article menu
Download PDFPDF
Original Article
The Antiemetic Efficacy and Safety of Prophylactic Metoclopramide for Elective Cesarean Delivery during Spinal Anesthesia
  1. Steven A. Lussos, M.D.*,
  2. Sanjay Datta, M.D.‡,
  3. Angela M. Bader, M.D.** and
  4. Marsha L. Thornhill, M.D.†
  1. From the Department of Anesthesia, Brigham and Women's Hospital, Boston, Massachusetts.
  2. *Staff Anesthesiologist, Fairfax Hospital, Falls Church, Virginia.
  3. **Assistant Professor of Anaesthesia, Harvard Medical School, Associate Director of Obstetric Anesthesia, Brigham and Women's Hospital.
  4. †Instructor in Anaesthesia, Harvard Medical School, Staff Anesthesiologist, Brigham and Women's Hospital.
  5. ‡Associate Professor of Anaesthesia, Harvard Medical School, Director of Obstetric Anesthesia, Brigham and Women's Hospital.
  1. Address reprint requests to Steven A. Lussos, M.D., Department of Anesthesia, Brigham and Women's Hospital, Boston, MA 02115.

Abstract

Background and Objectives. The efficacy and safety of intravenous metoclopramide administered prophylactically before elective cesarean delivery under spinal anesthesia was studied.

Methods. In a double-blind, randomized fashion, 42 ASA Physical Status I-II parturients at term were assigned to receive either 10-mg intravenous metoclopramide or an equal volume of normal saline before induction of spinal anesthesia. The occurrence of nausea and/or vomiting was recorded throughout the perioperative period until the patient was admitted to the recovery room. Neonatal acid-base status and neurobehavioral exams were obtained.

Results. Patients in the group receiving metoclopramide had a significantly lower incidence of nausea and vomiting both before and after delivery than the control group (14% versus 81% overall). All neonatal acid-base values were within normal limits and there were no significant differences in neurobehavioral exam results between the two groups.

Conclusions. Metoclopramide administered before induction of spinal anesthesia for cesarean delivery appears to significantly reduce both pre- and postdelivery emetic symptoms without apparent adverse effects on mother or neonate.

  • Anesthesia
  • obstetric
  • cesarean delivery
  • metoclopramide.

http://dx.doi.org/10.1136/rapm-00115550-199217030-00002

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.